Works matching DE "LENNOX-Gastaut syndrome"
Results: 747
Value of cannabidiol as adjunctive treatment for Lennox Gastaut syndrome: cost-effectiveness and budget impact analysis.
- Published in:
- BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-03972-9
- By:
- Publication type:
- Article
CANABIDIOL NA EPILEPSIA REFRATÁRIA DAS SÍNDROMES DE LENNOX-GASTAUT E DRAVET: REVISÃO SISTEMÁTICA.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 5, p. 1, doi. 10.54751/revistafoco.v16n5-123
- By:
- Publication type:
- Article
Safety and effectiveness of cenobamate in down syndrome: a case report.
- Published in:
- 2025
- By:
- Publication type:
- Letter
Late transience and persistence of contrast-induced encephalopathy: a case report and a literature update.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 6, p. 2187, doi. 10.1007/s10072-023-06649-4
- By:
- Publication type:
- Article
Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Electroclinical spectrum of generalized paroxysmal fast activity in adults without epileptic encephalopathy.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 6, p. 3857, doi. 10.1007/s10072-021-05808-9
- By:
- Publication type:
- Article
Eyelid myoclonia with absences, intellectual disability and attention deficit hyperactivity disorder: a clinical phenotype of the RORB gene mutation.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 5, p. 2059, doi. 10.1007/s10072-020-05031-y
- By:
- Publication type:
- Article
Perampanel treatment in Early-onset Epileptic Encephalopathy with infantile movement disorders associated with a de novo GRIN1 gene mutation: a 3-year follow-up.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A de novo mutation in SMC1A gene identified in a Chinese infant with nonclassical Cornelia de Lange syndrome and drug-resistant epilepsy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The utility of whole exome sequencing for identification of the molecular etiology in autosomal recessive developmental and epileptic encephalopathies.
- Published in:
- Neurological Sciences, 2020, v. 41, n. 12, p. 3729, doi. 10.1007/s10072-020-04619-8
- By:
- Publication type:
- Article
Current application of cannabidiol (CBD) in the management and treatment of neurological disorders.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Selection of treatment for ictal asystole patients based on EEG and ECG with temporary cardiac pacing.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Compound heterozygous mutations in PUS3 gene identified in a Chinese infant with severe epileptic encephalopathy and multiple malformations.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
GRIN2A: involvement in movement disorders and intellectual disability without seizures.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Identification of anti-epileptic natural products using zebrafish.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 177, doi. 10.33320/maced.pharm.bull.2022.68.04.081
- By:
- Publication type:
- Article
Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome.
- Published in:
- Journal of Market Access & Health Policy, 2017, v. 5, n. 1, p. N.PAG, doi. 10.1080/20016689.2017.1318691
- By:
- Publication type:
- Article
Vagus Nerve Stimulation in the Treatment of Patients with Pharmacoresistant Epilepsy: Our Experiences.
- Published in:
- Collegium Antropologicum, 2011, v. 35, n. 3, p. 755
- By:
- Publication type:
- Article
R1617Q epilepsy mutation slows Na<sub>V</sub>1.6 sodium channel inactivation and increases the persistent current and neuronal firing.
- Published in:
- Journal of Physiology, 2021, v. 599, n. 5, p. 1651, doi. 10.1113/JP280838
- By:
- Publication type:
- Article
Rare epilepsy syndromes: understanding treatment goals and management challenges.
- Published in:
- Learning Disability Practice, 2024, v. 27, n. 5, p. 32, doi. 10.7748/ldp.2023.e2230
- By:
- Publication type:
- Article
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
- Published in:
- 2022
- By:
- Publication type:
- Letter
Corpus Callosotomy: Editorial.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Identifying Factors Associated with the Recurrence of Tic Disorders.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 6, p. 697, doi. 10.3390/brainsci12060697
- By:
- Publication type:
- Article
Pharmacoresistant Epilepsy in Childhood: Think of the Cerebral Folate Deficiency, a Treatable Disease.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 11, p. 762, doi. 10.3390/brainsci10110762
- By:
- Publication type:
- Article
Ictal Asystole in Drug-Resistant Focal Epilepsy: Two Decades of Experience from an Epilepsy Monitoring Unit.
- Published in:
- Brain Sciences (2076-3425), 2020, v. 10, n. 7, p. 443, doi. 10.3390/brainsci10070443
- By:
- Publication type:
- Article
Chromosome fragility in the Lennox-Gastaut epilepsy syndrome.
- Published in:
- Journal of Intellectual Disability Research, 1992, v. 36, n. 5, p. 435, doi. 10.1111/j.1365-2788.1992.tb00561.x
- By:
- Publication type:
- Article
Rufinamide in patients with Lennox-Gastaut syndrome.
- Published in:
- Nursing: Research & Reviews, 2016, v. 6, p. 51, doi. 10.2147/NRR.S116114
- By:
- Publication type:
- Article
The Continued Need for Transparent Evidence on the Cost Effectiveness of Drugs for Rare Diseases.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Authors' Reply to Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome.
- Published in:
- PharmacoEconomics, 2020, v. 38, n. 11, p. 1237, doi. 10.1007/s40273-020-00945-z
- By:
- Publication type:
- Article
Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox-Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rufinamide A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 247, doi. 10.2165/11208630-000000000-00000
- By:
- Publication type:
- Article
ERRATUM.
- Published in:
- 2011
- Publication type:
- Correction Notice
The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK.
- Published in:
- PharmacoEconomics, 2010, v. 28, n. 3, p. 185, doi. 10.2165/11313640-000000000-00000
- By:
- Publication type:
- Article
RADIO-IMAGISTIC INVESTIGATIONS IN LENNOX-GASTAUT SYNDROME – CASE REPORT.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Comparison of efficacy and safety of corticosteroids and vigabatrin plus corticosteroids in infantile spasm: An open label randomized control trial.
- Published in:
- Professional Medical Journal, 2023, v. 30, n. 5, p. 598, doi. 10.29309/TPMJ/2023.30.05.7486
- By:
- Publication type:
- Article
Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study.
- Published in:
- Acta Neurologica Scandinavica, 2010, v. 122, n. 3, p. 202, doi. 10.1111/j.1600-0404.2010.01334.x
- By:
- Publication type:
- Article
Alteration of the anatomical covariance network after corpus callosotomy in pediatric intractable epilepsy.
- Published in:
- PLoS ONE, 2019, v. 14, n. 12, p. 1, doi. 10.1371/journal.pone.0222876
- By:
- Publication type:
- Article
Clobazam approved for seizure disorder.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 23, p. 2204, doi. 10.2146/news110077
- By:
- Publication type:
- Article
Levetiracetam for managing neurologic and psychiatric disorders.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 6, p. 541, doi. 10.2146/ajhp070607
- By:
- Publication type:
- Article
Is sulthiame effective and tolerated as add-on therapy for infants with epilepsy? A Cochrane Review summary with commentary.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Poster Presentations.
- Published in:
- Developmental Medicine & Child Neurology, 2021, v. 63, p. 13, doi. 10.1111/dmcn.14749
- Publication type:
- Article
Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CHD2‐related epilepsy: novel mutations and new phenotypes.
- Published in:
- Developmental Medicine & Child Neurology, 2020, v. 62, n. 5, p. 647, doi. 10.1111/dmcn.14367
- By:
- Publication type:
- Article
British Paediatric Neurology Association Annual Meeting, 29-31 January 2020, Assembly Buildings, Belfast.
- Published in:
- 2020
- Publication type:
- journal article
Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gene mutations in paediatric epilepsies cause NMDA-pathy, and phasic and tonic GABA-pathy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The ketogenic diet is effective for refractory epilepsy associated with acquired structural epileptic encephalopathy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Oral presentations.
- Published in:
- Developmental Medicine & Child Neurology, 2017, v. 59, p. 5, doi. 10.1111/dmcn.13622
- Publication type:
- Article